about
Systematic Reviews of Preclinical Animal Studies can Make Significant Contributions to Health Care and More Transparent Translational MedicineMeta-Research: Broadening the Scope of PLOS BiologyWhere Have All the Rodents Gone? The Effects of Attrition in Experimental Research on Cancer and StrokeCerebral collateral circulation in experimental ischemic strokeOn the predictive utility of animal models of osteoarthritisImproving the predictive value of interventional animal models dataDistinguishing between exploratory and confirmatory preclinical research will improve translationMinimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experimentsBedside to bench: a look at experimental research with a clinical trial checklistDispositional negativity: An integrative psychological and neurobiological perspectiveAnimal models of stroke: translational potential at present and in 2050The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of diseaseBig-data-based edge biomarkers: study on dynamical drug sensitivity and resistance in individuals.The Researchers' View of Scientific Rigor-Survey on the Conduct and Reporting of In Vivo Research.Evolution of ischemic damage and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal outcomes and statistical power for multi-centre preclinical trialsThe next step in translational research: lessons learned from the first preclinical randomized controlled trial.From Reproducibility to Translation in Neurodegenerative Disease.Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis.Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemiaResults of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia.Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar ratsOur time is now - how companion animal veterinarians can transform biomedical science.Oral administration of a novel lipophilic PPARδ agonist is not neuroprotective after rodent cerebral ischemia.Reproducibility and replicability of rodent phenotyping in preclinical studiesTwo-kidney one-clip is a pertinent approach to integrate arterial hypertension in animal models of stroke: Serial magnetic resonance imaging studies of brain lesions before and during cerebral ischemia.Paradigm Shift to Neuroimmunomodulation for Translational Neuroprotection in Stroke.Preclinical efficacy studies in investigator brochures: Do they enable risk-benefit assessment?PREPARE: guidelines for planning animal research and testing.Necessary, but Not Sufficient. The Benefit Concept in the Project Evaluation of Animal Research in the Context of Directive 2010/63/EU.The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials.Complexities, Confounders, and Challenges in Experimental Stroke Research: A Checklist for Researchers and Reviewers
P2860
Q24197752-2119965C-5AF8-467D-A2B7-22B154FEFD43Q24288788-97D393A7-402D-41E0-898C-A73F0BDA41DDQ24288791-87DB1D63-BFDB-4122-A73F-E3B98A02443EQ26765095-209A9F96-9B5E-4ACF-8FCF-F1C94A1947E5Q26781301-F0A2A788-73BC-4DC9-95AA-2AFDFE73A5DBQ27026822-7524847E-16FA-4D5A-87B4-3A7B5B88C6F9Q28538978-82A5AB37-4167-4C90-A872-F4889361E859Q28654987-0A9DFBA0-2D04-4276-9335-9B5E98F87F26Q28661031-22333D95-CCC2-455D-8D49-4A1A6258426DQ30368900-DD6E0862-D0DF-4BD2-825C-FA07F5E48BEAQ34700931-6DF1BD8C-C8AC-415E-9029-F38CAFF4369CQ35635673-536EFDDA-17B5-4AEB-B743-953C46C8E282Q35789759-CB03914F-CE87-4EB1-B9DE-3D12CAD7201AQ36211830-0E25507D-9124-4972-B348-00957E80CCF1Q36275582-76147A2B-3383-4528-9C73-EAA14978B2ECQ38770603-4609FDBF-0358-4C40-B372-A8CED18DE804Q38819341-30394DDA-3411-412B-8EBB-9E25A48191AFQ38849057-587AFF9E-FB66-4593-97F4-08C7FDD78CFBQ39179831-A562E992-AB7D-4713-84CD-62C74392BBF6Q41511386-FD90818C-1255-4B55-962A-A3DDCF593865Q42034211-A5148F61-0AFC-480D-BC37-D5084AF7DC3BQ43176059-FAF60364-EACE-4B6A-AF4A-9F52DB73EDB2Q47564690-E98F48EC-50B3-4A13-8ACE-9B423E336540Q50111076-F189012D-AF2E-49D6-8013-BB627086039CQ52091400-5B6B5D82-C0C7-4053-A5AA-C0BA3EB68F7EQ52564678-BBA6FEA0-CA0B-48ED-9A50-B6ED9DF801FEQ53278582-83BC1343-788F-4431-8878-B1BB29D9C6CBQ54981663-DAC5DEBE-D605-4194-8DA5-479E5FD8F63EQ55082366-F6B0A2D9-29B0-4059-BC9C-732CE37CB420Q55312738-44F97520-80CC-4319-AFEA-601C03D2A862Q56968979-E0B12EFE-992B-4C75-8478-B25328545709
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Bringing rigour to translational medicine.
@en
type
label
Bringing rigour to translational medicine.
@en
prefLabel
Bringing rigour to translational medicine.
@en
P2860
P50
P1476
Bringing rigour to translational medicine.
@en
P2860
P2888
P356
10.1038/NRNEUROL.2013.232
P407
P577
2013-11-19T00:00:00Z
P6179
1046334829